Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rPA Anthrax Vaccine vs AVA in Healthy Adults
NCT00170469Phase 2Completed
- Sponsor
- PharmAthene
- Start
- Mar 2005
- Primary completion
- Feb 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of anthrax rPA vaccine in anthrax (3 arms), sponsored by PharmAthene. Primary endpoint: Safety of rPA vaccine. Started Mar 2005; status: completed.
02
Drugs
anthrax rPA vaccine
03
Conditions
anthrax
Beyond the preview
Go deeper on NCT00170469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170469.